KF

Kelly Frye

RP Regeneron Pharmaceuticals: 24 patents #40 of 810Top 5%
📍 Mendham, NJ: #9 of 208 inventorsTop 5%
🗺 New Jersey: #3,122 of 69,400 inventorsTop 5%
Overall (All Time): #168,696 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
12331099 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2025-06-17
11806398 Citrate buffered VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2023-11-07
11732024 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2023-08-22
11084865 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2021-08-10
11066458 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2021-07-20
10857231 Formulations of VEG antagonist fusion proteins and method of manufacturing them Daniel Dix, Susan KAUTZ 2020-12-08
10464992 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2019-11-05
10406226 Method of manufacturing VEGF antagonist fusion proteins Daniel Dix, Susan KAUTZ 2019-09-10
10400025 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2019-09-03
9914763 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2018-03-13
9636400 VEGF specific fusion protein antagonist formulations Daniel Dix, Susan KAUTZ 2017-05-02
9580489 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2017-02-28
9511140 Stable VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2016-12-06
9416167 Stable liquid formulations of dimer VEGF antagonists Daniel Dix, Susan KAUTZ 2016-08-16
9340594 VEGF antagonist formulations for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2016-05-17
8921316 Stable liquid VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2014-12-30
8802107 VEGF antagonist formulations for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2014-08-12
8710004 Stable liquid VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2014-04-29
8481046 VEGF antagonist formulations for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2013-07-09
8404638 Dimer VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2013-03-26
8110546 VEGF antagonist formulations Daniel Dix, Susan KAUTZ 2012-02-07
8092803 VEGF antagonist formulations for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2012-01-10
7807164 Lyophilized VEGF antagonist formulations for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2010-10-05
7608261 VEGF antagonist formulations suitable for intravitreal administration Eric Furfine, Daniel Dix, Kenneth S. Graham 2009-10-27